Follow
Francesco Pappalardo
Francesco Pappalardo
Hospital Pharmacist, Catania Local Health Authority
Verified email at aspct.it
Title
Cited by
Cited by
Year
Elevation of transaminases associated with teriparatide treatment: a case report
F Pappalardo, L Fantini, V Caruso
European Journal of Hospital Pharmacy 29 (5), 290-293, 2022
12022
5PSQ-022 Drug-induced aplastic anaemia: an analysis of the FDA adverse event reporting system (FAERS)
F Pappalardo, MA D’agata, MA Khaleel, AH Khan, SMS Ghadzi
European Journal of Hospital Pharmacy 31 (Suppl 1), A173-A173, 2024
2024
4CPS-015 Assessment of in-hospital antibiotics consumption pattern according to the who aware classification in a local health authority
F Pappalardo, E Garaffo, MA D’agata
European Journal of Hospital Pharmacy 31 (Suppl 1), A58-A58, 2024
2024
Dispositivi medici: istituita la nuova Rete italiana di Dispositivo-vigilanza
MADA Ester Garaffo, Francesco Pappalardo, Pasquale Cananzi, Claudia La Cavera
Bollettino SIFO 69 (1), 40-49, 2023
2023
VALUTAZIONE DEL PROFILO DI SICUREZZA DELLE CAR-T TRAMITE IL DATABASE AMERICANO FAERS
DAMA Pappalardo Francesco
2022, v, 168 p. ISTISAN Congressi 22/C5, 2022
2022
Al via la nuova Rete Nazionale di Farmacovigilanza dell’AIFA
F Pappalardo, C Lamesta, S Oliverio, L Bellante, A Romagnoli, D Scala, ...
Bollettino SIFO 68 (5), 386-390, 2022
2022
5PSQ-136 Disproportionality analysis of the skin toxicity of ingenol mebutate using the FDA Adverse Event Reporting System database
F Pappalardo, V Rocco, C Polidori
European Journal of Hospital Pharmacy 28 (Suppl 1), A124-A124, 2021
2021
GESTIONE ADR A VACCINI COVID-19: COLLABORAZIONE FARMACISTA-ALLERGOLOGO
P Francesco, P Simonetta, G Barbara, P Fabio, R Alberto, C Gabriele
2021, v, 147 p. ISTISAN Congressi 21/C4, 2021
2021
5PSQ-067 Safety profile of pirfenidone and nintedanib in a real life setting: assessment of suspected adverse drug reactions in the Emilia Romagna region, Italy
F Pappalardo, F Pieraccini, B Gavioli, F Carnaccini, L Fantini, L Rossi
European Journal of Hospital Pharmacy 27 (Suppl 1), A180-A181, 2020
2020
REAZIONI AVVERSE DA TOCILIZUMAB E CANAKINUMAB OFF-LABEL NELLA AUSL ROMAGNA
P Francesco, R Vittoria, P Simonetta, R Lucia, G Barbara, P Fabio
2020, v, 87 p. ISTISAN Congressi 20/C2, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–10